The affordable medicines facility-malaria - A success in peril

Ambrose O. Talisuna; Seraphine Adibaku; Chioma N. Amojah; George K. Amofah; Vivian Aubyn; Alex Dodoo; Elizabeth Juma; Djermakoye H. Jackou; Sigsbert Mkude; Albert P. Okui; Benjamin Ramarosandratana; Shija J. Shija

doi:10.1186/1475-2875-11-370

The affordable medicines facility-malaria - A success in peril

Ambrose O. Talisuna
, Seraphine Adibaku
, Chioma N. Amojah
, George K. Amofah
, Vivian Aubyn
, Alex Dodoo
, Elizabeth Juma
, Djermakoye H. Jackou
, Sigsbert Mkude
, Albert P. Okui
, Benjamin Ramarosandratana
, Shija J. Shija

Centre for Tropical, Clinical Pharmacology & Therapeutics

University of Oxford
China Uganda Friendship Hospital
Federal Ministry of Health
Ministry of Health, Ghana
National Malaria Elimination Programme
Kenya Medical Research Institute
Programme National de Lutte Contre le Paludisme (PNLP - Niger)
National Malaria Control Programme (NMCP)
Uganda Ministry of Health
Programme National de Lutte Contre le Paludisme (PNLP-Madagascar)
Ministry of Health Zanzibar

Research output: Contribution to journal › Review article › peer-review

9 Citations (Scopus)

Abstract

The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.

Original language	English
Article number	370
Journal	Malaria Journal
Volume	11
DOIs	https://doi.org/10.1186/1475-2875-11-370
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

ACT
AMFm
Global fund
Malaria/economics
Malaria/treatment

Access to Document

10.1186/1475-2875-11-370

Cite this

@article{49df7037a17c488fb92e09b13625a10b,

title = "The affordable medicines facility-malaria - A success in peril",

abstract = "The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.",

keywords = "ACT, AMFm, Global fund, Malaria/economics, Malaria/treatment",

author = "Talisuna, \{Ambrose O.\} and Seraphine Adibaku and Amojah, \{Chioma N.\} and Amofah, \{George K.\} and Vivian Aubyn and Alex Dodoo and Elizabeth Juma and Jackou, \{Djermakoye H.\} and Sigsbert Mkude and Okui, \{Albert P.\} and Benjamin Ramarosandratana and Shija, \{Shija J.\}",

year = "2012",

doi = "10.1186/1475-2875-11-370",

language = "English",

volume = "11",

journal = "Malaria Journal",

issn = "1475-2875",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - The affordable medicines facility-malaria - A success in peril

AU - Talisuna, Ambrose O.

AU - Adibaku, Seraphine

AU - Amojah, Chioma N.

AU - Amofah, George K.

AU - Aubyn, Vivian

AU - Dodoo, Alex

AU - Juma, Elizabeth

AU - Jackou, Djermakoye H.

AU - Mkude, Sigsbert

AU - Okui, Albert P.

AU - Ramarosandratana, Benjamin

AU - Shija, Shija J.

PY - 2012

Y1 - 2012

N2 - The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.

AB - The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.

KW - ACT

KW - AMFm

KW - Global fund

KW - Malaria/economics

KW - Malaria/treatment

UR - https://www.scopus.com/pages/publications/84868492382

U2 - 10.1186/1475-2875-11-370

DO - 10.1186/1475-2875-11-370

M3 - Review article

C2 - 23137141

AN - SCOPUS:84868492382

SN - 1475-2875

VL - 11

JO - Malaria Journal

JF - Malaria Journal

M1 - 370

ER -

The affordable medicines facility-malaria - A success in peril

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this